Search
Search Funnelback University
- Refined by:
- Date: 2020
71 -
80 of
388
search results for news |u:www.enterprise.cam.ac.uk
Fully-matching results
-
First of new generation of cancer drugs granted European approval –…
https://www.enterprise.cam.ac.uk/news/first-of-new-generation-of-cancer-drugs-granted-european-approval/23 Oct 2020: 19 December 2014. First of new generation of cancer drugs granted European approval. ... Lynparza is an innovative new anti-cancer medicine that works in a different way to previously-marketed drugs. -
University of Cambridge launches new investment scheme for start-ups…
https://www.enterprise.cam.ac.uk/news/university-of-cambridge-launches-new-investment-scheme-for-start-ups/23 Oct 2020: 17 May 2012. University of Cambridge launches new investment scheme for start-ups. ... Last year, Cambridge Enterprise reviewed 54 new business ideas and made 11 investments totalling £640,000. -
New sensor could prolong the lifespan of high-temperature engines –…
https://www.enterprise.cam.ac.uk/news/new-sensor-could-prolong-the-lifespan-of-high-temperature-engines/23 Oct 2020: 19 September 2013. New sensor could prolong the lifespan of high-temperature engines. ... said Dr Michele Scervini, a postdoctoral researcher in the Department of Materials Science and Metallurgy, who developed the new thermocouple. -
Horizon Discovery establishes two new Centres of Excellence in…
https://www.enterprise.cam.ac.uk/news/horizon-discovery-establishes-two-new-centres-of-excellence-in-cambridge/23 Oct 2020: 11 March 2013. Horizon Discovery establishes two new Centres of Excellence in Cambridge. ... Horizon will also have an exclusive option to license new intellectual property developed. -
Cambridge Enterprise refreshes its Board with five new members –…
https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-refreshes-its-board-with-five-new-members/23 Oct 2020: The new members are: Professor Russell Cowburn, Tony Hickson, Professor Patrick Maxwell, Lesley Millar-Nicholson and Professor Anna Vignoles. ... for the commercialisation of IP from CRUK funded projects, new start-up creation, licences and corporate -
Cambridge Enterprise joins in £14m funding round for spin-out…
https://www.enterprise.cam.ac.uk/news/apcintex-series-a/23 Oct 2020: Share:. Cambridge Enterprise has joined in a £14 million Series A funding round into ApcinteX Limited, a University of Cambridge spin-out company developing a new therapy for haemophilia. ... Apcintex has developed a new treatment that seeks to turn -
Smart glass – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/smart-glass/23 Oct 2020: Professor Ulli Steiner and colleagues from the Cavendish Laboratory have developed a new coating which is both antireflective and self-cleaning. -
Designer piercings – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/designer-piercings/23 Oct 2020: of new drugs, and enabling more efficient disease diagnosis through DNA sequence detection. ... Cavendish Laboratory, who worked with the teams at UCL and Southampton to develop the new technique. -
Under pressure – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/under-pressure/23 Oct 2020: The patterned anvils technology removes many of the difficulties associated with achieving repeatable electrical measurements under high pressure. -
PhoreMost raises £2.5m to identify new targets for therapeutics –…
https://www.enterprise.cam.ac.uk/news/phoremost-raises-2-5m-to-identify-new-druggable-targets-for-therapeutics/23 Oct 2020: 8 April 2015. PhoreMost raises £2.5m to identify new targets for therapeutics. ... Dr Chris Torrance was a founder of Horizon Discovery (LSE: HZD), which completed its IPO in March 2014, raising £37.8 million of new money. .
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.